Company news

AnnJi Pharmaceutical Co., Ltd. news in 2026

AnnJi Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)

October 5, 2026

Empowering the SBMA Community: AnnJi Highlights Patient & Family Forum and Shares AJ201 Scientific Advancement at the 2026 KDA Conference

March 4, 2026